evaluate the pharmaceuticals and biotechnology company pfizer on top glp-1's 2 Companies Poised to Capitalize Rise of GLP-1 Weight Loss Drugs GLP-1s and the Unintended Consequences

Ecnoglutide was already approved to treat type 2 diabetes when Pfizer claimed rights to the drug known locally as Xianweiying in Mainland China via a deal valued at up to $495 million

PIB Backgrounder : 01 APR 2026 10:48AM by PIB Delhi Introduction Diabetes is a chronic disease that occurs when the pancreas does not produce adequate insulin, or when the body cannot effectively use the insulin it produces, leading to high blood sugar

Pugliese G, Iacobini C, Pesce CM, Menini S

In the meantime, some functional medicine providers use a narrower range of values when evaluating micronutrient blood levels to help identify early stages of health issues